Many public, NGO, and private-sector service-delivery systems are suitably matched to the requirements of providing injectable contraceptives in India, including the ability to ensure choice and service delivery quality. This operations research study was designed to demonstrate the feasibility of providing injectable contraceptives in private medical practices and to contribute to the body of scientific literature on the acceptability of this method in India. DKT India and EngenderHealth formed a partnership with the Population Council’s Frontiers in Reproductive Health program to conduct this study in Gujarat. The ability to generate recommendations is limited, however, by the special characteristics of the physicians who took part in the DKT India program, the high loss to follow-up rate among DMPA clients, and the small sample size. Therefore, the report offers the following points as tentative recommendations for program managers to consider as they work toward expanding contraceptive choice for women in India: the DMPA injectable contraceptive should be offered through social marketing programs in India, in conjunction with professional support services such as IEC materials and professional development opportunities; the price of DMPA should be reduced; and DMPA should be made available in multiple service delivery systems.
Introducing DMPA injectable contraceptives to private medical practitioners in urban Gujarat, FRONTIERS Final Report. Washington, DC: Population Council, 2003.
Frontiers in Reproductive Health